[ad_1]
new York, May 29, 2021 /PRNewswire/ – Juan Monteverde, Founder and managing partner Monteverde & Associates PC, Was rated as a national securities company Top 50 In the 2018-2020 ISS Securities Class Action Service Report, headquartered in the Empire State Building, New York New York City,investigating Strongbridge Biopharma plc (“SBBP” or “Company”) (SBBP) in connection with the proposed acquisition of Xeris Pharmaceuticals, Inc. According to the terms of the agreement, SBBP shareholders will receive 0.7840 Xeris shares they own. SBBP shareholders will also get a contingent right of value up to 1.00 USD After certain trigger events are realized, the payment will be made in cash per share or equivalent Xeris stock.
The focus of the investigation is whether Strongbridge Biopharma plc and its board of directors violated securities laws and/or breached fiduciary obligations to the company due to 1) failure to conduct fair procedures and 2) whether the valuation of the transaction was appropriate.
Click here for more information: https://www.monteverdelaw.com/case/strongbridge-biopharma-plc. It is free, and you do not need to bear any fees or obligations.
About Monteverde & Associates PC
We are a national class-action securities litigation law firm that has recovered millions of dollars and is committed to protecting shareholders from corporate misconduct.We are included Top 50 In the 2018-2020 ISS Securities Class Litigation Service Report. Our lawyers have extensive experience in litigating mergers and acquisitions and securities class actions. Mr. Monteverde was named a rising star in the securities litigation field by Super Lawyers in 2013 and 2017-2019. The award is awarded to less than 2.5% of lawyers in a specific field.He was also selected Martindale-Hubbell was named the top lawyer of the year 2017-2020. Our company’s recent success includes a major victory that changed the law to lower the standard of liability under Article 14(e) of the Ninth Circuit’s Transaction Law. Since then, our company succeeded in maintaining this victory by dismissing the interim filing order granted by the U.S. Supreme Court. Emulex Company v. Wajabedian, 139 S. Ct. 1407 (2019). In addition, over the years, the company has recovered or obtained more than a dozen cash mutual funds for shareholders in merger and acquisition class actions.
If you own the company’s common stock and want to get more information for free and protect your investment, please visit our website Or contact Juan E. Monteverde, left. Or via email jmonteverde@monteverdelaw.com Or call (212) 971-1341.
contact:
Juan E. Monteverde, left.
MONTEVERDE & ASSOCIATES PC
Empire State Building
Suite 4405, 350 Fifth Avenue
New York, New York 10118
United States
jmonteverde@monteverdelaw.com
Phone: (212) 971-1341
Lawyer advertisement. (C) 2021 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Previous results do not guarantee similar results for any future events.
View original content and download multimedia:http://www.prnewswire.com/news-releases/shareholder-alert-monteverde–associates-pc-announces-an-investigation-of-strongbridge-biopharma-plc–sbbp-301301997.html
Source Monteverde & Associates PC
[ad_2]
Source link
